Home ›

Publications

Filters: Author is Porta, M  [Clear All Filters]
2013
Porta M, Vandenbroucke JP, Ioannidis JP, Sanz S, Fernandez E, Bhopal R, et al. Trends in citations to books on epidemiological and statistical methods in the biomedical literature. PloS one. 2013;8(5):e61837. Abstract
2011
Parker LA, Porta M, Lumbreras B, López T, Guarner L, Hernández-Aguado I, et al. Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. European Journal of Epidemiology. 2011;26(3):229-36. Abstract
Martrat G, Maxwell CA, Tominaga E, Porta M, Bonifaci N, Gomez-Baldo L, et al. Exploring the link between MORF4L1 and risk of breast cancer. Breast cancer research : BCR. 2011;13(2):R40. Abstract
2009
Porta M, Crous-Bou M, Wark PA, Vineis P, Real FX, Malats N, et al. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes. Mutation research. 2009;682(2-3):83-93. Abstract
Porta M, López T, Pumarega J, Jariod M, Crous-Bou M, Marco E, et al. In pancreatic ductal adenocarcinoma blood concentrations of some organochlorine compounds and coffee intake are independently associated with KRAS mutations. Mutagenesis. 2009;24(6):513-21. Abstract
Crous-Bou M, Porta M, López T, Jariod M, Malats N, Morales E, et al. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma. Environmental and molecular mutagenesis. 2009;50(5):421-30. Abstract
Crous-Bou M, Porta M, Morales E, López T, Carrato A, Puigdomènech E, et al. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study. Cancer causes & control : CCC. 2009;20(5):591-9. Abstract
2008
Crous-Bou M, De Vivo I, Porta M, Pumarega JA, López T, Alguacil J, et al. CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma. Digestive diseases and sciences. 2008;53(5):1417-21. Abstract
Porta M, Ferrer-Armengou O, Pumarega J, López T, Crous-Bou M, Alguacil J, et al. Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids. Journal of clinical epidemiology. 2008;61(7):695-704. Abstract
Pérez G, Porta M, Borrell C, Casamitjana M, Bonfill X, Bolibar I, et al. Interval from diagnosis to treatment onset for six major cancers in Catalonia, Spain. Cancer detection and prevention. 2008;32(3):267-75. Abstract
2007
Morales E, Porta M, Vioque J, López T, Mendez MA, Pumarega J, et al. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. Journal of epidemiology and community health. 2007;61(7):641-9. Abstract
Porta M, Hernández-Aguado I, Lumbreras B, Crous-Bou M. "Omics" research, monetization of intellectual property and fragmentation of knowledge: can clinical epidemiology strengthen integrative research? Journal of clinical epidemiology. 2007;60(12):1220-5; discussion 1226-8. Abstract
Crous-Bou M, Porta M, López T, Jariod M, Malats N, Alguacil J, et al. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas. 2007;35(2):135-41. Abstract